Neoadjuvant chemotherapy reduces the expression rates of ER, PR, HER2, Ki67, and P53 of invasive ductal carcinoma

To analyze whether neoadjuvant chemotherapy (NAC) changes the expression rates of invasive ductal carcinoma (IDC) markers: estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), Ki67, and P53. This was a retrospective study of 112 IDC patients who underw...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Medicine (Baltimore)
Main Authors: Peng, Jian-Heng, Zhang, Xiang, Song, Jun-Long, Ran, Liang, Luo, Rong, Li, Hong-Yuan, Wang, Yong-Hong
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Health 2019
Assuntos:
5750
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6336639/
https://ncbi.nlm.nih.gov/pubmed/30633152
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000013554
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados